Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Webinar: Debunking myths and unveiling opportunities in listed private equity

Webinar: Debunking myths and unveiling opportunities in listed private equity

In this webinar, our three speakers discussed the case for listed private equity amid the prevailing wide discounts to NAV. While rising interest rates, muted global M&A activity and volatile public markets have caused investors concerns recently, the sector is benefitting from a secular trend of companies staying private for longer, as well as the increasing sector expertise and value-add provided to portfolio companies by top private equity managers.

Hear from Alan Gauld, senior investment director of the abrdn Private Equity team and lead portfolio manager of abrdn Private Equity Opportunities Trust, Hamish Mair, managing director and head of private equity at Columbia Threadneedle Investments and Steven Tredget, partner at Oakley Capital, in a conversation moderated by Milosz Papst, head of content – investment trusts at Edison.

Want to learn more? Download our latest report by Milosz Papst, Listed private equity – Performing a balancing act.

< Previous
Next >

You may also be interested in these:

Investment Companies

Budget Breakdown with Gervais Williams: What does it really mean?
sharesoc pic

Investment Companies

ShareSoc webinar – The Biotech Growth Trust

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free